Medical and Pharmaceutical Tempus AI builds on FDA win with Median partnership for lung cancer detection Median secured FDA 510(k) approval for eyonis LCS on Feb. 9 Rowan DunneFebruary 23, 2026
Medical and Pharmaceutical Median Technologies clears hurdle on the way to regulatory acceptance in EU and US The company has met a key requirement for regulatory submissions in the US and Europe Joseph MortonApril 3, 2025
AI and Autonomy Median Technologies and European Investment Bank agrees to €37.5M loan The tech leverages machine learning to analyze imaging data generated by low-dose computed tomography Joseph MortonJanuary 28, 2025